Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

PreciseDx

start up
United States - New York, NY
  • 22/08/2024
  • Series B
  • $20,700,000

PreciseDx® is innovating oncology diagnostics, leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven, disease analysis. Combining AI with our patented Morphology Feature Array® (MFA), PreciseDx provides access to unmatched disease insights and accurate, actionable intelligence for more comprehensive decision-making throughout the cancer care continuum.


Related People

Wayne BrinsterFounder

Wayne Brinster United States - Mays Landing, New Jersey

Serially Successful CEO – Diagnostics, Devices, Life Sciences - Strategic Executive Leader with 19+ years of driving revenue and promoting transformation within Diagnostics, Life Science and Biotech industry

Throughout my career as a vision-driven, goal-focused executive I have built a solid track record of improving processes and procedures balancing focus across business development, maximizing revenues and returns, harnessing team strengths, and building consensus among executives and stakeholders.

Proven track record of multimillion-dollar revenue growth, rapid operational turn around, and “right-fit” operational infrastructure that grow with the organization. A trusted partner to Board Leadership and relied upon to identify and capitalize on opportunities with an ability to think out of the box and build an environment of innovation have enabled me to form a well-earned reputation for delivering consistent improvements to the success of the organization.